Overview

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients

Status:
Unknown status

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the antibody response in dialysis patents to each of the three influenza vaccine strains included in the licensed seasonal flu vaccine (Formulation 2011-2012).

Phase:

Phase 4

Details

Lead Sponsor:

National Cheng-Kung University Hospital

Treatments:

Vaccines